# Biomarkers-and-Clinical-Covariates-for-Predicting-Prostate-Cancer-Recurrence
Prostate cancer poses high recurrence risks post-prostatectomy. This study assessed whether combining 40 biomarkers with clinical factors (age, PSA, Gleason score, tumor stage) improves 5-year recurrence prediction compared to using clinical covariates alone.
